These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Pleuropulmonary disease associated with dopamine agonist therapy.
    Author: Bhatt MH, Keenan SP, Fleetham JA, Calne DB.
    Journal: Ann Neurol; 1991 Oct; 30(4):613-6. PubMed ID: 1686385.
    Abstract:
    Artificial dopamine agonists are widely employed for the treatment of idiopathic parkinsonism. Pleuropulmonary disease has previously been reported to occur with the use of bromocriptine and mesulergine. We report similar adverse effects induced by the newer agonists lisuride and cabergoline. All these agents are tetracyclic ergot derivatives. This suggests a causal link between ergot-derived dopamine agonists and pleuropulmonary disease.
    [Abstract] [Full Text] [Related] [New Search]